> ## Content Index > Fetch the complete content index at: https://www.morningowl.io/llms.txt > Use this file to discover other available public pages before exploring further. # Morning note · September 10, 2026 - URL: https://www.morningowl.io/products/2026-09-10-pro/ - Published: 2026-09-10T13:05:08.000Z - Updated: 2026-09-15T12:26:07.000Z - Author: morningowl - Tags: VMC, WST, VTRS, META, MLM ☕ Rise and shine. We read a day's worth of market noise so you don't have to. These names actually moved the conversation. How to read each name below: first line = how morningowl sentiment moved since yesterday, second = where it stands now (-100 to +100). ▸ Vulcan Materials Company (VMC) ▼ Down 28 since yesterday Sentiment now -24 Produces crushed stone, sand, gravel, asphalt, and concrete for construction and infrastructure projects. Each group's sentiment and how much it drove today's overall move: Analyst sentiment -97; led today's move. Retail sentiment -52; added to it. News sentiment -9; added to it. Analyst commentary centered on Wells Fargo's shift to Underweight from Equal-Weight, alongside a price target cut to $254 from $305\. Retail chatter echoed that same downgrade while flagging a fresh 52-week low and debating whether to average down near the $230 level. News coverage placed the move in a broader context, noting Vulcan Materials among four downgrades tied to weaker outlooks. All three groups aligned on a cautious read, differing mainly in emphasis: analysts on the rating change, retail on price levels, and news on the sector-wide sweep. As of September 9, 2026, Vulcan Materials carried a P/E of 29.0, while its last close sat at the 1.6 percentile of its trailing three-month range and the 0.4 percentile of its 12-month range, down 12.3% over the past month. The company is scheduled to report earnings on October 28, 2026\. As of September 1, 2026, analyst opinion leaned favorable, with 19 favorable, 10 neutral, and 1 cautious across 30 analysts. ▸ West Pharmaceutical Services (WST) ▲ Up 23 since yesterday Sentiment now +38 Manufactures containment and delivery systems for injectable drugs and healthcare products. Each group's sentiment and how much it drove today's overall move: Analyst sentiment +92; led today's move. News sentiment +94; added to it. Both groups are centered on the same development: UBS reiterating its favorable rating on WST and lifting its price target to $415 from $340\. Analyst commentary frames it plainly as the reaffirmed favorable stance paired with the higher price target. News commentary adds the specific attribution, naming UBS analyst Doug Schenkel behind the move. The two groups align fully in direction and substance, differing only in that the news side supplies the analyst's name. As of 2026-09-09, West Pharmaceutical Services carried a P/E of 42.1, with its last close near the top of its trailing 12-month range at the 80.2 percentile but lower within its 3-month range at the 20.6 percentile, and down 4.3% over the past month. It is scheduled to report earnings on 2026-10-21\. As of 2026-09-01, coverage leaned favorable, with 21 favorable, 2 neutral, and no cautious across 23 analysts. ▸ Viatris (VTRS) ▲ Up 18 since yesterday Sentiment now +47 Manufactures and distributes prescription drugs, generics, and biosimilars to healthcare providers and patients globally. Each group's sentiment and how much it drove today's overall move: Retail sentiment +92; led today's move. News sentiment +94; added to it. Analyst sentiment +31; added to it. Retail chatter centered almost entirely on Lexicon's pipeline catalysts, with Viatris appearing only as a tagged ticker rather than a subject of discussion, leaving its enthusiasm tangential to the stock itself. News commentary took a favorable view grounded in Viatris fundamentals, pointing to a Q2 with adjusted EPS up 11% and free cash flow doubling year-over-year as support for a continued re-rating. Analyst commentary echoed that constructive tone, as Leerink Partners initiated coverage with a favorable rating and a $20 price target. The news and analyst groups thus align on Viatris' cash generation and pipeline progress, while the retail posts sit apart, driven by an unrelated name. As of 2026-09-09, Viatris last closed at the 52.4 percentile of its trailing three-month range and the 85.3 percentile of its twelve-month range, up 2.1% over the past month, placing it near the top of its longer trailing span. As of 2026-09-01, coverage leans favorable across seventeen analysts, with eleven favorable, five neutral, and one cautious. The company is scheduled to report earnings on 2026-11-04, as of 2026-09-10. ▸ Meta Platforms (META) ▲ Up 15 since yesterday Sentiment now +25 Operates social media platforms Facebook, Instagram, WhatsApp, and develops virtual and augmented reality hardware. Each group's sentiment and how much it drove today's overall move: Analyst sentiment +85; led today's move. News sentiment +60; added to it, on unusually heavy chatter. Retail sentiment +33; added to it. Analyst commentary is centered on Meta's Muse AI agent launch that drove a roughly 6.5% surge, headlined by JPMorgan's move to Overweight on AI potential, alongside a favorable multi-year legal settlement and the Stilla.ai acquisition. News commentary, amid unusually heavy chatter, echoed the same upgrade and its "meaningful headroom" thesis, framing Muse as an answer to long-standing monetization doubts, and flagged ARK's rotation of $27.9M into META from GOOGL. Retail commentary zeroed in on the concrete terms, Doug Anmuth's $820 price target, up from $640, while also tracking technical levels like a cross above the 200 EMA and resistance near 684\. All three lean favorable and converge on the JPMorgan upgrade and Muse as the catalysts, with retail adding a chart-driven angle. As of 2026-09-09, Meta Platforms carried a P/E of 22.9, with its last close at the 92.1 percentile of its trailing three-month range and the 63.9 percentile of its twelve-month range, up 9.9% over the past month. As of 2026-09-01, coverage leaned favorable across 71 analysts, with 62 favorable, 9 neutral, and none cautious. The company is scheduled to report earnings on 2026-10-27. ▸ Martin Marietta Materials (MLM) ▲ Up 14 since yesterday Sentiment now +20 Supplies crushed stone, sand, gravel, concrete, and asphalt for infrastructure and construction projects. Each group's sentiment and how much it drove today's overall move: Analyst sentiment +92; led today's move. News sentiment +18; added to it, on unusually heavy chatter. Analyst commentary centered on Wells Fargo's rating change from Equal-Weight to Overweight, alongside a lifted price target of $609 from $581\. News commentary, drawing unusually heavy chatter, focused on the same Wells Fargo upgrade to Overweight without dwelling on the figures. Both groups pointed in a favorable direction, aligned on the ratings shift; the analyst side added the specific price target while the news side simply amplified the upgrade itself. As of 2026-09-09, Martin Marietta Materials carried a P/E of 14.7, with its last close at the 1.6 percentile of its trailing 3-month range and 0.4 of its 12-month range, down 8.3% over the past month. As of 2026-09-01, analyst coverage leaned favorable, with 17 favorable, 13 neutral, and 1 cautious. The company is scheduled to report earnings on 2026-11-02. That's a wrap on today's chatter, the owls are roosting, the charts can wait. ☕🦉 This is not investment advice. morningowl is a publisher, not a registered investment adviser. We may hold positions in any security mentioned. Past performance and historical commentary patterns do not predict future results. Our data and analysis are provided "as is" and may contain inaccuracies; we accept no liability for errors or for any decisions made in reliance on them.